In a nation spread across thousands of islands where access to specialised healthcare can often mean the difference between life and death, one institution has emerged as the cornerstone of cardiovascular excellence and a symbol of hope for millions. The National Cardiovascular Centre Harapan Kita (NCCHK), widely known as RS Jantung dan Pembuluh Darah Harapan Kita, is far more than a hospital. It is Indonesia’s flagship cardiovascular institution, a national referral centre, an educational powerhouse, a surgical innovator, and the central node of a vast healthcare ecosystem dedicated to fighting heart and vascular diseases.
For decades, this centre has carried an extraordinary responsibility, not merely to treat patients but also to shape the future of cardiovascular care across the archipelago. Rather than concentrating expertise in one location, the National Cardiovascular Centre Harapan Kita serves as a mentor institution that elevates the capabilities of healthcare providers. The philosophy of a Healthy Heart and a mission of fostering cardiovascular wellness was recognised by the awarding organisation World Business Outlook a Singapore-based business news publication to Award it two Titles: Best Cardiovascular Specialty Hospital Indonesia 2026 and Leading National Referral Hospital for Cardiovascular Services Indonesia 2026.
The philosophy of a healthy heart and its mission to foster cardiovascular wellness have been recognised by World Business Outlook, a Singapore-based business news publication, which honoured the hospital with two prestigious titles: Best Cardiovascular Specialty Hospital Indonesia 2026 and Leading National Referral Hospital for Cardiovascular Services Indonesia 2026.
As Indonesia’s leading cardiovascular specialty hospital, the institution functions as the apex referral centre for complex heart and blood vessel diseases. Patients arrive from every corner of the country seeking expert diagnosis, advanced interventions, and specialised treatments. NCCHK’s influence reaches much further than direct patient care. Guided and supported by Indonesia’s Ministry of Health, the centre spearheads a nationwide cardiovascular referral network that connects more than 500 regional general hospitals. Through this extensive framework, NCCHK actively nurtures and strengthens cardiovascular services across the country by supporting the development of modern facilities, advanced medical equipment, clinical infrastructure, and highly skilled healthcare professionals.
This ecosystem-driven approach has transformed the hospital into a national catalyst for medical advancement and this was well noted by the magazine’s Jury. By sharing knowledge, training medical personnel, and helping regional hospitals build specialised competencies, NCCHK ensures that quality cardiovascular care can reach populations far beyond major urban centers. It is a strategy rooted in sustainability, collaboration, and national healthcare resilience.
Fostering Arrhythmia Care
One of the most remarkable examples of the hospital’s leadership can be found in its renowned arrhythmia division. Since its development in 2000, the division has played a pioneering role in advancing arrhythmia care throughout Indonesia. Cardiac arrhythmias, which involve abnormalities in the rhythm of the heart, can range from minor irregularities to life-threatening conditions requiring highly specialised intervention. Recognising the increasing importance of electrophysiology and rhythm management, NCCHK invested early in creating one of the nation’s most comprehensive arrhythmia programmes. Today, the division stands as one of the hospital’s leading centres of excellence.
Beyond treating complex cases, the arrhythmia division serves as a vital educational hub. Cardiologists from across Indonesia and international medical communities come to Harapan Kita to learn advanced arrhythmia management, diagnostic techniques, and innovative treatment procedures. Through structured training and mentorship, the division contributes to the growth of future specialists capable of addressing cardiac rhythm disorders. This dual role as both a treatment centre and academic institution highlights the unique character of NCCHK, where patient care and professional development operate hand in hand.
Driving Impact in Numbers
The PJNHK Arrhythmia Division Services recorded the following annual procedural volumes during their last fully published baseline year (2022) *:
• PPM (Permanent Pacemaker) Implantations: 1,804 patients
• Holter Monitoring: 1,403 patients
• Conventional Ablation: 199 patients
• Three-Dimensional (3D) Ablation: 105 patients
• Tilt Table Test (Tes Meja Jungkit): 66 patients
• Brugada Provocation: 21 patients
• Cardioversion: 15 patients
• CRT (Cardiac Resynchronisation Therapy) Implantations: 14 patients
• ICD (Implantable Cardioverter-Defibrillator) Implantations: 12 patients
• LAA (Left Atrial Appendage) Closure: 5 patients
Equally significant is the hospital’s role as a trusted national gateway for cardiovascular information and public engagement. For many Indonesians navigating cardiac health concerns, NCCHK serves as a reliable source of guidance regarding heart and vascular services, registration procedures, specialist consultations, and patient support channels. Its commitment to accessibility and transparency reinforces public trust and strengthens its identity as a patient-centred institution.
Excellence in Congenital Heart Care
Among the crown jewels of its clinical ecosystem is the Paediatric Cardiac Surgery Division, a department whose achievements have profoundly shaped the landscape of congenital heart care in Indonesia. Established as part of the Harapan Kita Heart Centre, the division specialises in treating congenital heart diseases in children, adolescents, and adults, while also addressing acquired heart diseases affecting younger populations. Behind every successful procedure lies a multidisciplinary team of highly experienced paediatric cardiac surgeons, anaesthesiologists, intensivists, nurses, and rehabilitation professionals who collaborate to provide seamless care.
In 1985, the institution successfully performed the first congenital heart surgery, a ventricular septal defect (VSD) operation that marked a historic breakthrough for Indonesian healthcare. What began as a pioneering endeavour has evolved into one of the nation’s most accomplished paediatric cardiac programmes. According to National Library of Medicine (National Centre for Biotechnology Information), by 2022, 21,687 patients had received treatment and 1200 paediatric cardiac surgery cases (800-900 pump cases) were performed annually through this division. The department’s success reflects decades of unwavering commitment to ensuring that children born with heart conditions have the opportunity to live healthier and fuller lives.
The Lifelong Impact of Harapan Kita
The hospital’s impact extends across the entire lifespan of cardiovascular care, and nowhere is this more evident than in its Adult Cardiac Surgery Services. As one of the institution’s flagship service lines, the adult cardiac surgery department consistently embraces technological advancement and surgical innovation. Modern cardiovascular medicine continues to evolve rapidly, and Harapan Kita has demonstrated a clear determination to remain at the forefront of these developments.
The hospital’s implementation of Minimally Invasive Cardiac Surgery (MICS) techniques has reduced surgical trauma while accelerating recovery times. Advanced Maze procedures offer surgical solutions for complex arrhythmias, helping restore normal heart rhythm and improve quality of life. Off-pump coronary artery bypass grafting represents a significant advancement in bypass surgery, minimising certain risks associated with traditional heart-lung machine usage.
The department’s expertise in advanced vascular surgery is particularly impressive. Complex procedures involving the aortic arch and thoracoabdominal aorta demand extraordinary technical precision and multidisciplinary coordination. The capability to perform hemiarch replacements, total arch reconstructions, and thoracoabdominal aortic surgeries demonstrates the exceptional level of specialisation available within the hospital. Such interventions are among the most challenging in cardiovascular medicine, requiring not only advanced technology but also highly skilled surgical teams operating that reflect the hospital’s advanced surgical capabilities.
The scale of this achievement becomes evident when examining surgical volumes. In 2022 alone, the adult cardiac surgery facility successfully performed 2,846 operations. Behind each number is a patient whose life trajectory was altered through timely intervention, expert surgical care, and comprehensive postoperative support. Collectively, these procedures illustrate the immense trust that patients place in Harapan Kita and the institution’s ability to deliver world-class cardiovascular services at scale.
The hospital also excels in Primary PCI (Percutaneous Coronary Intervention), an emergency procedure using balloon angioplasty and stents to clear blocked coronary arteries. Backed by advanced technology and skilled specialists, this treatment restores blood flow during acute heart attacks (STEMI), protects heart muscle, reduces complications, and can improve clinical outcomes when delivered promptly. The hospital has treated 2,842 patients and carried out 1,256 procedures, maintaining a strong 96.2% success rate till date.
Reinforcing Surgical Infrastructure
Recognising the growing demand for these sophisticated services, Harapan Kita expanded its surgical infrastructure. Since 2013, the hospital has operated four dedicated cardiac surgical theatres. These state-of-the-art operating rooms provide the environment necessary for conducting a wide range of complex cardiovascular procedures safely and efficiently. The investment reflects the institution’s commitment to continuously enhancing its capacity while maintaining the highest standards of patient care.
Furthermore, Indonesia’s Ministry of Health and Japan’s Tokushukai Medical Group recently designated Harapan Kita Heart and Blood Vessel Hospital as Asia’s largest cardiovascular education and research hub. Led by President Director Iwan Dakota, the Indonesian government and Tokushukai partnership will construct a new building to double the hospital’s capacity from 400 to 800 beds. International specialists from Japan and other countries will practice at the facility regularly.
What truly distinguishes the National Cardiovascular Centre Harapan Kita, however, is not any single division, technology, or statistic. Its greatest strength lies in the interconnected ecosystem it has built over decades. It is an ecosystem where patient care, education, innovation, research, infrastructure development, and national healthcare collaboration function as a unified whole. Surgeons, cardiologists, nurses, educators, administrators, researchers, and policymakers work together toward a common goal: reducing the burden of cardiovascular disease and improving the quality of life for millions of Indonesians.
Layanan Vaksinasi (Vaccination Services)
Another service provided by NCCHK is its vaccination facility through which it helps the vulnerable people like older adults, children, pregnant women, and cardiovascular patients. At the National Cardiovascular Centre Harapan Kita, qualified professionals provide safe, high-quality immunizations. For heart patients, receiving influenza and pneumonia vaccines is critical to preventing respiratory infections that can severely worsen cardiac conditions. Additionally, vaccination is a vital preparation for Hajj and Umrah pilgrims. It fulfils strict entry health regulations for the Kingdom of Saudi Arabia while protecting travellers from infectious health risks encountered during their journey.
From pioneering congenital heart surgeries and training future specialists to advancing complex adult cardiac procedures and strengthening referral networks across hundreds of hospitals, NCCHK exemplifies what modern healthcare leadership looks like.
Today, the rhythm of Harapan Kita extends far beyond the operating theatre or consultation room. It resonates through regional hospitals, educational programmes, community outreach initiatives, and countless patient success stories across Indonesia. It is a rhythm powered by excellence, innovation, and compassion, ensuring that the heart of Indonesian cardiovascular care continues to beat stronger than ever and this earned it the accolades from World Business Outlook.
*The Hospital has not publicly released any data till date after the base year 2022.
